No linked studies yet.
Omega-3 Triglyceride Fish Oil 1100 mg
Product analysis
Omega-3 Triglyceride Fish Oil 1100 mg supplies EPA and DHA for heart-related nutrition and offers good value for these active fats.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The precise forms of the listed fats are not clearly disclosed. That limits a confident comparison of their quality and absorption.
Ingredient Transparency70
The amounts and relevant component details are stated, making the active fats easier to distinguish from total oil weight. The precise forms remain unspecified.
Value For Money92
Value is favorable for the EPA and combined EPA and DHA supplied. DHA on its own offers more moderate value.
Customer Satisfaction89
Customer feedback is very positive across a substantial review history. Reviews support the pattern of satisfaction without proving health benefits.
Product Focus68
The clearest role is heart-related nutrition through EPA and DHA. The wider range of skin, eye, joint and focus aims has more mixed or limited support.
- Format
Softgel - Container
- 120 Softgel(s)
- Per serving
- $0.37
- Also available
Omega-3 Triglyceride Fish Oil 1100 mg$29.95- Customer rating
- 4.8 · 2,951 ratings
Goals
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 15 Calorie(s) | |
Calories from Fat | 10 Calorie(s) | |
Total Fat | 1.5 Gram(s) | |
Molecularly distilled Fish Oil | 1326 mg | |
Total Omega-3 Fatty Acids | 1100 mg | |
Eicosapentaenoic Acid | 729 mg | |
Docosahexaenoic Acid | 275 mg | |
Other Omega-3 Fatty Acids | 96 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability83
Molecular Form and Bioavailability
EPA Concentration Density
Oxidation Protection
Dose, Safety & Label Transparency82
Absolute EPA Dose per Serving
EPA-Centric Ratio
Purity and Contaminant Testing
Value100
Price per Gram of EPA
How this ingredient is rated
Active Ingredient Quality & Bioavailability74
Omega-3 Molecular Form
Purification & Filtration Method
Third-Party Purity & Potency Verification
Source & Sustainability
Dose, Safety & Label Transparency94
Total Active Omega-3 Dose (EPA + DHA)
Omega-3 Potency & Concentration
EPA & DHA Individual Disclosure
Oxidation Protection (Stabilizers)
Value100
Cost Per Gram of Active EPA + DHA
How this ingredient is rated
Active Ingredient Quality & Bioavailability72
Molecular Form & Absorption Potential
Source Purity & Oxidative Protection
Dose, Safety & Label Transparency73
EPA & DHA Label Specificity
Active Ingredient Concentration
Third-Party Purity Verification
Value100
Price per 1000mg of EPA+DHA
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
- Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
- Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
- Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
- Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.